Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs†
Abstract
The first example of a trimorphic cocrystal involving two active
Please wait while we load your content...
Associated articles
Supplementary files
- Crystal structure data CIF (51K)
- Experimental details, list of some recently approvedcombination drugs, ORTEP diagrams, DSC and TGA analysis of Form I,DSC analysis of Form II, packing diagram of Form III,photomicrographs from HSM experiments, PXRD patterns of slurry,melting, and SDG experiments PDF (712K)
- Crystal structure data TXT (51K)
Article information
- Article type
- Communication
- Submitted
- 05 Mar 2009
- Accepted
- 29 May 2009
- First published
- 19 Jun 2009
CrystEngComm, 2009,11, 1823-1827
Permissions
Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs
S. Aitipamula, P. S. Chow and R. B. H. Tan, CrystEngComm, 2009, 11, 1823 DOI: 10.1039/B904616J
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
